Atlas Trials

Prostate Carcinoma Metastatic in the Bone

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Prostate Carcinoma Metastatic in the Bone

RecordFirmDate
sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT04033432)Northwestern University2019-09-20
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03751436)Roswell Park Cancer Institute2019-08-02
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate (NCT03582475)Jonsson Comprehensive Cancer Center2019-01-11
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer (NCT03344211)University of Southern California2018-11-21
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency (NCT03442556)University of Washington2018-08-24
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer (NCT03406858)Barbara Ann Karmanos Cancer Institute2018-06-07
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies (NCT03217747)M.D. Anderson Cancer Center2017-08-02
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord (NCT02713269)M.D. Anderson Cancer Center2016-08-29
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway (NCT02598895)University of Washington2016-01-26
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression (NCT02555189)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2015-12-01
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer (NCT02215161)University of California, San Francisco2014-09-02

Track Prostate Carcinoma Metastatic in the Bone automatically

Every clearance here is in the API, with alerts when new ones post.